Admedus is a global healthcare company that develops, commercialises and distributes next generation medical technologies and devices. Our mission is to provide patients around the world with a better quality of life through access to our leading medical solutions and products.Learn More
Admedus Wins 2016 Australian Manufacturer of the Year Award
After triumphing in the Most Innovative category, Admedus also took out the night’s biggest award ‘Manufacturer of the Year’. In August 2014 Admedus opened its state-of-the-art bio-manufacturing facility in Malaga, WA, and has experienced huge success in exporting its bio-scaffold regenerative medicine product, CardioCel, since then.
May 14th 2016Find out more
A day with Europe’s leading cardiovascular surgeons
In April, I had the privilege of spending the day with over forty of Europe’s leading cardiovascular surgeons. The purpose – an Admedus workshop to discuss the use of CardioCel to reconstruct heart valves and its potential in the future treatment of heart valve disease. Held in Amsterdam, the experts meeting shed light on the critical issues and […]
May 5th 2016Find out more
Are all cardiovascular tissue patches the same?
While some people may claim that all cardiovascular tissue patches (pericardial patches/bioscaffolds) are fundamentally the same, we know this is not the case. Surgeons and patients alike are searching for a bioscaffold that is safe, strong and durable. More specifically, they want a material that doesn’t calcify (harden) at the site of surgery and can […]
April 5th 2016Find out more
Admedus inks exclusive distro deal with Coroneo
Admedus (ASX:AHZ) has inked an exclusive distribution agreement with Coroneo to sell its extra aortic annuloplasty ring and other heart valve surgery instruments in Germany and the U.K.
January 27th 2016Find out more